| First Author | Okuma A | Year | 2013 |
| Journal | Immunity | Volume | 38 |
| Issue | 3 | Pages | 450-60 |
| PubMed ID | 23453632 | Mgi Jnum | J:194832 |
| Mgi Id | MGI:5474889 | Doi | 10.1016/j.immuni.2012.11.016 |
| Citation | Okuma A, et al. (2013) Enhanced Apoptosis by Disruption of the STAT3-IkappaB-zeta Signaling Pathway in Epithelial Cells Induces Sjogren's Syndrome-like Autoimmune Disease. Immunity 38(3):450-60 |
| abstractText | Sjogren's syndrome (SS) is an autoimmune disease characterized by exocrinopathy that leads to dry eye and mouth. Although lymphocyte infiltration into exocrine glands and the generation of autoantibodies have been reported in SS, its pathogenic mechanism remains elusive. Here, we show that mice lacking the transcriptional regulator IkappaB-zeta developed SS-like inflammation characterized by lymphocyte-infiltrated dacryoadenitis and SS-associated autoantibodies. In particular, epithelial cells, but not hematopoietic cells, lacking IkappaB-zeta were essential for the development of inflammation. IkappaB-zeta-deficient epithelial cells in the lacrimal glands exhibited enhanced apoptosis even in the absence of lymphocytes. Administration of caspase inhibitors ameliorated the inflammation, indicating the critical role of caspase-mediated apoptosis. Furthermore, epithelial cell-specific STAT3-deficient mice developed SS-like inflammation with impaired IkappaB-zeta expression in the lacrimal glands. Thus, this study reveals a pathogenic mechanism of SS in which dysfunction of epithelial cells caused by disruption of STAT3-mediated IkappaB-zeta induction elicits the activation of self-reactive lymphocytes. |
